[Federal Register Volume 68, Number 145 (Tuesday, July 29, 2003)]
[Notices]
[Pages 44538-44539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-19198]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: A U.S. Clinical Trial Site To Conduct Evaluations of 
Topical Microbicides in Heterosexual Women and Men, Contract 
Solicitation Number 2003-N-00822

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis

[[Page 44539]]

Panel (SEP): A U.S. Clinical Trial Site to Conduct Evaluations of 
Topical Microbicides in Heterosexual Women and Men, Contract 
Solicitation Number 2003-N-00822.
    Times and Dates:
7 p.m.-8 p.m., August 14, 2003 (Open).
8 a.m.-8:30 a.m., August 15, 2003 (Open).
8:30 a.m.-5 p.m., August 15, 2003 (Closed).

    Place: The Westin Atlanta North Perimeter Hotel, 7 Concourse 
Parkway, Atlanta, GA 30327, Telephone 770.395.3900.
    Status: Portions of the meeting will be closed to the public in 
accordance with provisions set forth in section 552b(c) (4) and (6), 
Title 5 U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Pub. L. 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
Contract Solicitation Number 2003-N-00822.
    For Further Information Contact: Andrew Vernon, Office of the 
Director, National Center for HIV, STD, and TB Prevention, CDC, 1600 
Clifton Road, NE, MS-E07, Atlanta, GA 30333, Telephone 404.639.8006.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: July 23, 2003.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 03-19198 Filed 7-28-03; 8:45 am]
BILLING CODE 4163-18-P